Showing results (1711-1720 of 6,070) with videos related to
Sort By:
Pageof 607
Pathogens and Disease|January 29, 2021
Got mutants? How advances in chlamydial genetics have furthered the study of effector proteinsShelby E Andersen, Lanci M Bulman, Brianna Steiert, et al.The International Journal of Oral & Maxillofacial Implants|December 15, 2011
Effect of splinted and nonsplinted impression techniques on the accuracy of fit of fixed implant prostheses in edentulous patients: a comparative studyPanos Papaspyridakos, Kunal Lal, George Shelby White, et al.Seminars in Immunopathology|March 3, 2022
Atherosclerosis and multi-organ-associated pathologiesW Coles Keeter, Shelby Ma, Natalie Stahr, et al.Chemical Research in Toxicology|January 10, 2023
Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)Shamema Nasrin, Shelby Coates, Keti Bardhi, et al.Dermatologic Clinics|November 21, 2022
Targeted Therapy and Immunotherapy in Nonmelanoma Skin CancerNader Aboul-Fettouh, Shelby L Kubicki, Leon Chen, et al.Developmental Cell|August 17, 2010
beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2Shelby A Blythe, Sang-Wook Cha, Emmanuel Tadjuidje, et al.Journal of Invertebrate Pathology|April 8, 2000
Parasitism-linked block of host plasma melanizationK S Shelby, O A Adeyeye, B M Okot-Kotber, et al.Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1993
Administration of dehydroepiandrosterone to burned mice preserves normal immunologic competenceB A Araneo, J Shelby, G Z Li, et al.Expert Opinion on Therapeutic Patents|December 15, 2016
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)Stanton F McHardy, Hua-Yu Leo Wang, Shelby V McCowen, et al.Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship|December 13, 2016
The Pad Project: A Global Initiative Uniting WomenMichele Raines, Shelby L Garner, Lori A Spies, et al.Pageof 607